China clinical trial has experienced rapid growth over the past five years, driven by favorable policy, accelerated innovative drug developed, and continuous R&D investment
Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report · page 7 of 58
The slide uses a comparative bar chart structure to contrast high growth in China (29% CAGR) against stable growth in the U.S. (3% CAGR).
Consulting deck · industry_trends · summarize · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 2/2 list 1/1 source-note 1/1 title 1/1
Components 5
bar-vertical bar-vertical bullet source-note action-title
Tools 2
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.